Most recent update: Friday, June 14, 2019 - 08:47

Bariatric News - Cookies & privacy policy

You are here

GERD treatments and costs

LINX Reflux System reduces costs vs. laparoscopic Nissen fundoplication

LINX is a flexible ring of small magnets surgeons place around the lower part of the oesophagus, the body’s natural barrier to reflux, during a minimally invasive procedure.

Treatment with the LINX Reflux Management System reduced medical costs more than laparoscopic Nissen fundoplication (LNF), a more invasive anti-reflux surgery, and more than offsets the slightly higher cost of the procedure, according to a study presented at the 2019 Annual Meeting of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES 2019). The research was partially funded by Ethicon, in collaboration with Highmark Health’s VITAL Innovation Platform, a test-and-learn environment for health innovations.

“The higher initial cost of a LINX procedure compared to a Nissen fundoplication is perceived as a drawback by insurers, which made getting insurance approvals challenging,” said lead researcher Dr Blair Jobe, Director, Esophageal and Lung Institute at Allegheny Health Network. “This study suggests that perception may be short-sighted in that insurance plans can provide better care for their GERD patients at a similar cost to laparoscopic Nissen fundoplication when you factor in the greater reductions in medical costs after the procedure.”

 LINX is a flexible ring of small magnets surgeons place around the lower part of the oesophagus, the body’s natural barrier to reflux, during a minimally invasive procedure. The magnetic ring expands when a patient swallows to allow food to enter the stomach but then contracts to prevent stomach contents from flowing back into the oesophagus and causing GERD, a condition that affects about 20 percent of people in the US. In LNF, a surgeon wraps a portion of the upper stomach (fundus) around the lower part of the oesophagus to help prevent acid from moving up into the oesophagus.

The prospective observational study was performed at Highmark Health’s Allegheny Health Network, a health system serving western Pennsylvania, in conjunction with Highmark, the region’s largest health insurance company. Researchers compared the total procedural cost and the disease-related and overall medical claim costs 12 months before and 12 months after a LINX procedure (180 patients) or LNF (1,131 patients).

The study found the mean PMPM (per member per month) medical reimbursement claims related to upper gastrointestinal (GI) disease one year after LINX dropped by 66 percent (US$305 to US$104) compared to 46 percent (US$233 to US$126) after LNF.

Overall PMPM medical reimbursement claims decreased by 10.7 percent for LINX patients and only by 1.4 percent for LNF patients. Specific reimbursements for proton pump inhibitors (PPIs), acid suppression drugs for gastrointestinal reflux disease (GERD), dropped by 95 percent after LINX and by 90 percent after LNF.

The median cost of a LINX procedure was US$13,522 (mean US$14,379) and US$13,388 (mean US$13,691) for LNF, a difference that researchers say is offset or surpassed by a lower cost of care for the insurer in the one year following surgery.

“This study demonstrated that the LINX System was cost effective and should be more widely covered by insurers,” said Tom O’Brien, President, Worldwide Endomechanical, Ethicon. “Ethicon will continue to help support studies that enable clinicians, patients, insurers and health systems to make the best possible decisions about which treatments work best for which patients and at what cost.”

Previous studies on LINX showed 88 percent of patients reported that bothersome heartburn had been eliminated five years after treatment, 85 percent were free from dependence on daily reflux medication  and 99 percent of patients eliminated regurgitation, a common symptom of GERD. Patients also report significant improvements in quality of life. 

Want more stories like this? Subscribe to Bariatric News!

Bariatric News
Keep up to date! Get the latest news in your inbox. NOTE: Bariatric News WILL NOT pass on your details to 3rd parties. However, you may receive ‘marketing emails’ sent by us on behalf of 3rd parties.